Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 44
Titolo Tipologia Data di pubblicazione Autori File
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 02 - Intervento a convegno 2023 Lisa PaganiPaolo PrevitaliClizia ChinelloGiulia CapitoliGiulia RiscaRenato Alberto SinicoBarbara TrezziAndrea LombardiAndrea GoriAlessandra BanderaCristina MeregalliGuido CavalettiFulvio Magni +
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 01 - Articolo su rivista 2023 Pagani, LisaChinello, CliziaRisca, GiuliaCapitoli, GiuliaCriscuolo, LucreziaPiga, IsabellaMuscatello, AntonioFavalli, AndreaGori, AndreaBandera, AlessandraMagni, Fulvio +
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 01 - Articolo su rivista 2023 Bernasconi D.Squillace N.Muscatello A.Bandera A.Gori A. +
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 02 - Intervento a convegno 2022 Lisa PaganiClizia ChinelloAllia MahajnehFrancesca ClericiLucrezia CriscuoloAndrea FavalliAlessandra BanderaAndrea LombardiAntonio Muscatello +
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 02 - Intervento a convegno 2022 Pagani, LChinello, CMahajneh, AClerici, FCriscuolo, LCapitoli, GRisca, GFavalli, ABandera, ALombardi, AMuscatello, AGori, AMagni, F +
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 02 - Intervento a convegno 2022 Pagani, LChinello, CMahajneh, AClerici, FPanarello, GFavalli, ABandera, AMuscatello, AGori, AMagni, F +
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) 99 - Altro 2022 Gobbini A.Favalli A.Bandera A.Gori A. +
Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study 01 - Articolo su rivista 2022 Scaravilli, VittorioMadotto, FabianaMuscatello, AntonioBellani, GiacomoPesenti, AntonioBandera, AlessandraGrasselli, Giacomo +
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 01 - Articolo su rivista 2022 Favalli A.Gobbini A.Marongiu L.Granucci F.Bandera A.Gori A. +
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 02 - Intervento a convegno 2021 Lisa PaganiClizia ChinelloAllia MahajnehFrancesca ClericiGaia PanarelloAndrea FavalliAlessandra BanderaAntonio MuscatelloAndrea GoriFulvio Magni +
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 01 - Articolo su rivista 2021 Puoti M.Bandera A.Bonfanti P.Gori A.Lapadula G. +
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 01 - Articolo su rivista 2021 Muscatello A.Grasselli G.Bandera A.Puoti M. +
Impact of orotracheal intubation and mechanical ventilation on the microbiota of the lung in the development of Ventilator- Associated Pneumonia 02 - Intervento a convegno 2019 R. PinciroliA. VargioluA. BanderaA. GoriG. Citerio +
Microbiota in ICU, not only a gut problem 01 - Articolo su rivista 2019 Bandera, AMuscatello, ACiterio, G +
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 01 - Articolo su rivista 2019 Puoti M.Bandera A.Bonfanti P.Lapadula G. +
Combination antifungal therapy for invasive mold infections among pediatric patients with hematological malignancies: Data from a real-life case-series 01 - Articolo su rivista 2019 Longhi B.Migliorino G. M.Bandera A.Rizzari C.Gori A.Colombini A. +
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir 01 - Articolo su rivista 2018 Bandera A.Lapadula G.Gori A. +
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 01 - Articolo su rivista 2018 Puoti M.Bandera A.Bonfanti P.Lapadula G. +
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 01 - Articolo su rivista 2018 Squillace, NicolaMuscatello, AntonioMaloberti, AlessandroGiannattasio, CristinaSoria, AlessandroGori, AndreaBandera, Alessandra +
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 01 - Articolo su rivista 2018 Puoti M.Bandera A.Bonfanti P.Lapadula G. +
Mostrati risultati da 1 a 20 di 44
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile